Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Gavras, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 96 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stefanadis, C; Manolis, A; Dernellis, J; Tsioufis, C; Tsiamis, E; Gavras, I; Gavras, H; Toutouzas, P
      Acute effect of clonidine on left ventricular pressure-volume relation in hypertensive patients with diastolic heart dysfunction

      JOURNAL OF HUMAN HYPERTENSION
    2. Gavras, I; Gavras, H
      Role of alpha(2)-adrenergic receptors in hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    3. Sugiyama, F; Churchill, GA; Higgins, DC; Johns, C; Makaritsis, KP; Gavras, H; Paigen, B
      Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci

      GENOMICS
    4. Kintsurashvili, E; Duka, I; Gavras, I; Johns, C; Farmakiotis, D; Gavras, H
      Effects of ANG II on bradykinin receptor gene expression in cardiomyocytesand vascular smooth muscle cells

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    5. Gavras, I; Manolis, AJ; Gavras, H
      The alpha(2)-adrenergic receptors in hypertension and heart failure: experimental and clinical studies

      JOURNAL OF HYPERTENSION
    6. Kintsurashvili, E; Gavras, I; Johns, C; Gavras, H
      Effects of antisense oligodeoxynucleotide targeting of the alpha(2B)-adrenergic receptor messenger RNA in the central nervous system

      HYPERTENSION
    7. Gavras, H; Brunner, HR
      Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure

      HYPERTENSION
    8. DeStefano, AL; Gavras, H; Heard-Costa, N; Bursztyn, M; Manolis, A; Farrer, LA; Baldwin, CT; Gavras, I; Schwartz, F
      Maternal component in the familial aggregation of hypertension

      CLINICAL GENETICS
    9. Duka, I; Kintsurashvili, E; Gavras, I; Johns, C; Bresnahan, M; Gavras, H
      Vasoactive potential of the B-1 bradykinin receptor in normotension and hypertension

      CIRCULATION RESEARCH
    10. Elijovich, F; Laffer, CL; Amador, E; Gavras, H; Bresnahan, MR; Schiffrin, EL
      Regulation of plasma endothelin by salt in salt-sensitive hypertension

      CIRCULATION
    11. Gavras, I; Gavras, H
      Angiotensin-converting enzyme inhibitors

      HYPERTENSION MEDICINE
    12. Zhao, ZH; Makaritsis, K; Francis, CE; Gavras, H; Ravid, K
      A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    13. Gavras, I; Gavras, H
      The antiarrhythmic potential of angiotensin II antagonism: Experience withlosartan

      AMERICAN JOURNAL OF HYPERTENSION
    14. Gavras, H
      Update on the clinical pharmacology of candesartan cilexetil

      AMERICAN JOURNAL OF HYPERTENSION
    15. Duka, I; Gavras, I; Johns, C; Handy, DE; Gavras, H
      Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction

      GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM
    16. Levy, D; DeStefano, AL; Larson, MG; O'Donnell, CJ; Lifton, RP; Gavras, H; Cupples, LA; Myers, RH
      Evidence for a gene influencing blood pressure on chromosome 17 - Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study

      HYPERTENSION
    17. Makaritsis, KP; Johns, C; Gavras, L; Gavras, H
      Role of alpha-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice

      HYPERTENSION
    18. Nicolaou, M; DeStefano, AL; Gavras, I; Cupples, LA; Manolis, AJ; Baldwin, CT; Gavras, H; Farrer, LA
      Genetic predisposition to stroke in relatives of hypertensives

      STROKE
    19. Gavras, H
      Effect of ramipril on cardiovascular events in high-risk patients.

      NEW ENGLAND JOURNAL OF MEDICINE
    20. Gavras, H; Gavras, I
      Commentary: Implications for the pathophysiology of hypertension and heartfailure derived from clinical experience with drugs modifying the renin-angiotensin system

      DRUGS, ENZYMES AND RECEPTORS OF THE RENIN-ANGIOTENSIN SYSTEM: CELEBRATING A CENTURY OF DISCOVERY
    21. Gavras, H
      Historical evolution of angiotensin II receptor blockers: Therapeutic advantages

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    22. Gavras, I; Manolis, A; Gavras, H
      Genetic epidemiology of essential hypertension

      JOURNAL OF HUMAN HYPERTENSION
    23. Baldwin, CT; Schwartz, F; Baima, J; Burzstyn, H; DeStefano, AL; Gavras, I; Handy, DE; Joost, O; Martel, T; Manolis, A; Nicolaou, M; Bresnahan, M; Farrer, L; Gavras, H
      Identification of a polymorphic glutamic acid stretch in the alpha(2B)-adrenergic receptor and lack of linkage with essential hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    24. Manolis, AJ; Tsalopoulos, E; Ramos, C; Katsaros, K; Dalabiras, P; Hatzissavas, J; Foussas, S; Gavras, I; Bresnahan, M; Gavras, H
      Benefits of central sympathetic suppression with clonidine after acute myocardial infarction

      ADVANCES IN THERAPY
    25. Gavras, I; Gavras, H
      Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: Results from a 26-week, double-blind, multicentre study

      CURRENT MEDICAL RESEARCH AND OPINION
    26. Gavras, I; Gavras, H
      Safety and tolerability of eprosartan

      PHARMACOTHERAPY
    27. Makaritsis, KP; Johns, C; Gavras, I; Altman, JD; Handy, DE; Bresnahan, MR; Gavras, H
      Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype

      HYPERTENSION
    28. Baima, J; Nicolaou, M; Schwartz, F; DeStefano, AL; Manolis, A; Gavras, I; Laffer, C; Elijovich, F; Farrer, L; Baldwin, CT; Gavras, H
      Evidence for linkage between essential hypertension and a putative locus on human chromosome 17

      HYPERTENSION
    29. Makaritsis, KP; Handy, DE; Johns, C; Kobilka, B; Gavras, I; Gavras, H
      Role of the alpha(2B)-adrenergic receptor in the development of salt-induced hypertension

      HYPERTENSION
    30. Schwartz, F; Baldwin, CT; Baima, J; Gavras, H
      Mitochondrial DNA mutations in patients with orthostatic hypotension

      AMERICAN JOURNAL OF MEDICAL GENETICS
    31. Gavras, I; Manolis, AJ; Gavras, H
      The economics of therapeutic advances - The paradigm of sympathetic suppression in chronic heart failure

      ARCHIVES OF INTERNAL MEDICINE
    32. Gavras, H; Gavras, I
      The renin-angiotensin system and the heart

      HORMONES AND THE HEART IN HEALTH AND DISEASE
    33. MANOLIS AJ; OLYMPIOS C; SIFAKI M; SMIRNIOUDIS N; HANDANIS S; ARGIRAKIS S; KATSAROS C; GAVRAS I; GAVRAS H
      CHRONIC SYMPATHETIC SUPPRESSION IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE

      Clinical and experimental hypertension
    34. GAVRAS H; CHRYSANT SG; NIEDERMAN AL; MARBURY TC; GOLDSTEIN R; CONRADI E
      EVALUATION OF ENALAPRIL COMBINED WITH DILTIAZEM ER IN PATIENTS WITH STAGE-3-4 ESSENTIAL-HYPERTENSION

      Clinical and experimental hypertension
    35. BALBI AL; FRANCO RJS; BARRETTI P; GAVRAS I; GAVRAS H
      RENAL-ARTERY CLIPPING ATTENUATES THE PROGRESSION OF ADRIAMYCIN NEPHROPATHY

      American journal of hypertension
    36. MANOLIS AJ; BELDEKOS D; HANDANIS S; HARALABIDIS G; HATZISSAVAS J; FOUSSAS S; COKKINOS DV; BRESNAHAN N; GAVRAS I; GAVRAS H
      COMPARISON OF SPIRAPRIL, ISRADIPINE, OR COMBINATION IN HYPERTENSIVE PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY - EFFECTS ON LVH REGRESSION AND ARRHYTHMOGENIC PROPENSITY

      American journal of hypertension
    37. MONTEAGUDO PT; GAVRAS H; KOHLMANN O; RIBEIRO AB; ZANELLA MT
      THE INFLUENCE OF VASCULAR VASOPRESSIN ACTION ON BLOOD-PRESSURE PROFILE IN TYPE-I DIABETICS WITH SEVERE AUTONOMIC NEUROPATHY

      Journal of hypertension
    38. ELIJOVICH F; LAFFER CL; GAVRAS H; SCHIFFRIN EL
      SODIUM SENSITIVITY OF BLOOD-PRESSURE IN ESSENTIAL HYPERTENSIVE PATIENTS - A ROLE FOR ENDOTHELIN

      Hypertension
    39. HANDY DE; JOHNS C; BRESNAHAN MR; TAVARES A; BURSZTYN M; GAVRAS H
      EXPRESSION OF ALPHA(2)-ADRENERGIC RECEPTORS IN NORMAL AND ATHEROSCLEROTIC RABBIT AORTA

      Hypertension
    40. Makaritsis, KP; Gavras, H; Du, Y; Chobanian, AV; Brecher, P
      alpha(1)-adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E deficient mice

      HYPERTENSION
    41. MONTEAGUDO PT; GAVRAS H; KOHLMANN O; RIBEIRO AB; ZANELLA MT
      ABNORMAL-BLOOD PRESSURE PROFILE IN DIABETIC-PATIENTS WITH SEVERE AUTONOMIC NEUROPATHY - INFLUENCE OF VASOPRESSIN

      Diabetologia
    42. MANOLIS AJ; TSALOPOULOS E; RAMOS C; KATSAROS K; DALABIRAS P; HATZISSAVAS J; FOUSSAS S; GAVRAS I; BRESNAHAN M; GAVRAS H
      BENEFITS OF CENTRAL SYMPATHETIC SUPPRESSION WITH CLONIDINE AFTER ACUTE MYOCARDIAL-INFARCTION

      Circulation
    43. DESTEFANO AL; BALDWIN CT; BURZSTYN M; GAVRAS I; HANDY DE; JOOST O; MARTEL T; NICOLAOU M; SCHWARTZ F; STREETEN DHP; FARRER LA; GAVRAS H
      AUTOSOMAL-DOMINANT ORTHOSTATIC HYPOTENSIVE DISORDER MAPS TO CHROMOSOME 18Q

      American journal of human genetics
    44. GAVRAS I; GAVRAS H
      THE CALCIUM-CHANNEL ANTAGONIST CONTROVERSY

      American family physician
    45. BAKRIS GL; KUSMIREK SL; SMITH AC; GAVRAS I; GAVRAS H
      CALCIUM ANTAGONISM ABOLISHES THE ANTIPRESSOR ACTION OF VASOPRESSIN (V-1) RECEPTOR ANTAGONISM

      American journal of hypertension
    46. BAKRIS G; BURSZTYN M; GAVRAS I; BRESNAHAN M; GAVRAS H
      ROLE OF VASOPRESSIN IN ESSENTIAL-HYPERTENSION - RACIAL-DIFFERENCES

      Journal of hypertension
    47. MANOLIS AJ; BELDEKOS D; HATZISSAVAS J; FOUSSAS S; COKKINOS D; BRESNAHAN M; GAVRAS I; GAVRAS H
      HEMODYNAMIC AND HUMORAL CORRELATES IN ESSENTIAL-HYPERTENSION - RELATIONSHIP BETWEEN PATTERNS OF LVH AND MYOCARDIAL-ISCHEMIA

      Hypertension
    48. HANDY DE; JOHNS C; BRESNAHAN M; GAVRAS H
      EXPRESSION OF ALPHA(2)-ADRENERGIC RECEPTOR IN NORMAL AND ATHEROSCLEROTIC RABBIT AORTA

      Hypertension
    49. MANOLIS AJ; OLYMPIOS C; SIFAKI M; HANDANIS S; ARGIRAKIS S; KATSAROS C; GAVRAS I; GAVRAS H
      CHRONIC SYMPATHETIC SUPPRESSION IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE

      Hypertension
    50. MANOLIS AJ; BELDEKOS D; HATZISSAVAS J; FOUSSAS S; COKKINOS D; BRESNAHAN M; GAVRAS I; GAVRAS H
      HEMODYNAMIC AND HORMONAL CORRELATES IN ESSENTIAL-HYPERTENSION

      Hypertension
    51. KOHLMANN O; CESARETTI ML; GINOZA M; TAVARES A; ZANELLA MT; RIBEIRO AB; RAMOS OL; LEEMAN SE; GAVRAS I; GAVRAS H
      ROLE OF SUBSTANCE-P IN BLOOD-PRESSURE REGULATION IN SALT-DEPENDENT EXPERIMENTAL-HYPERTENSION

      Hypertension
    52. MANOLIS AJ; OLYMPIOS C; SIFAKI M; HANDANIS S; COKKINOS D; BRESNAHAN M; GAVRAS I; GAVRAS H
      COMBINED SYMPATHETIC SUPPRESSION AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN CONGESTIVE-HEART-FAILURE

      Hypertension
    53. CHRYSANT SG; GAVRAS H; NIEDERMAN AL; MARBURY TC; GOLDSTEIN R
      CLINICAL UTILITY OF LONG-TERM ENALAPRIL DILTIAZEM ER IN STAGE-3-4 ESSENTIAL-HYPERTENSION

      Journal of clinical pharmacology
    54. DESTEFANO AL; GAVRAS H; BURZSTYN M; GAVRAS I; HANDY D; JOOST O; NICOLAOU M; STREETEN D; FARRER LA; BALDWIN CT
      GENOME WIDE SEARCH FOR GENES CAUSING FAMILIAR ORTHOSTATIC INTOLERANCESYNDROME

      American journal of human genetics
    55. GAVRAS I; MANOLIS A; GAVRAS H
      DRUG-THERAPY FOR HYPERTENSION (VOL 55, PG 1823, 1997)

      American family physician
    56. GAVRAS I; MANOLIS A; GAVRAS H
      DRUG-THERAPY FOR HYPERTENSION

      American family physician
    57. GAVRAS I; GAVRAS H
      COMMENTARY ON KOSTIS REPORT FROM SOLVD

      American journal of hypertension
    58. WALL BM; HUCH KM; RUNYAN KR; WILLIAMS HH; GAVRAS H; COOKE R
      EFFECTS OF VASOPRESSIN V-1-RECEPTOR BLOCKADE DURING ACUTE AND SUSTAINED HYPOVOLEMIC HYPOTENSION

      American journal of physiology. Regulatory, integrative and comparative physiology
    59. JOHNS C; GAVRAS I; HANDY DE; SALOMAO A; GAVRAS H
      MODELS OF EXPERIMENTAL-HYPERTENSION IN MICE

      Hypertension
    60. MANOLIS AJ; OLYMPIOS C; SIFAKI M; HANDANIS S; FOUSSAS S; BRESNAHAN M; GAVRAS I; GAVRAS H
      EFFECTS OF COMBINED SYMPATHETIC SUPPRESSION AND ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITION IN CONGESTIVE-HEART-FAILURE (CHF)

      Hypertension
    61. KOHLMANN O; CESARETI ML; GINOZA M; ZANELLA MT; RIBEIRO AB; LEAMAN SE; GAVRAS I; GAVRAS H
      INFLUENCE OF SALT-DEPENDENCY ON THE CARDIOVASCULAR EFFECTS OF A SPECIFIC NONPEPTIDE ANTAGONIST OF SUBSTANCE-P RECEPTOR IN EXPERIMENTAL-HYPERTENSION

      Hypertension
    62. HANDY DE; GAVRAS H
      ROLE OF AN E-BOX IN REGULATING-ALPHA(2A)-ADRENERGIC RECEPTOR EXPRESSION

      Hypertension
    63. BAKRIS GL; KUSMIREK SL; SMITH AC; GAVRAS I; GAVRAS H
      CALCIUM-ANTAGONISTS PREVENT REDUCTIONS IN ARTERIAL-PRESSURE MEDIATED BY VASOPRESSIN RECEPTOR ANTAGONISM

      Hypertension
    64. MANOLIS A; GAVRAS I; GAVRAS H
      CLONIDINE AND HEART-FAILURE - RESPONSE

      Hypertension
    65. FROHLICH ED; GAVRAS H
      SYMPOSIUM ON GENE-REGULATION IN HYPERTENSION AND CARDIOVASCULAR-DISEASES

      Hypertension
    66. HANDY DE; GAVRAS H
      EVIDENCE FOR CELL-SPECIFIC REGULATION OF TRANSCRIPTION OF THE RAT ALPHA(2A)-ADRENERGIC RECEPTOR GENE

      Hypertension
    67. TAVARES A; HANDY DE; BOGDANOVA NN; ROSENE DL; GAVRAS H
      LOCALIZATION OF ALPHA(2A)-ADRENERGIC AND ALPHA(2B)-ADRENERGIC RECEPTOR SUBTYPES IN BRAIN

      Hypertension
    68. GAVRAS I; GAVRAS H
      CARDIOPROTECTIVE POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS

      Brazilian journal of medical and biological research
    69. HANDY DE; GAVRAS H
      ROLE OF CAMP IN TRANSCRIPTION OF THE RAT ALPHA2A-ADRENERGIC RECEPTOR GENE

      Circulation
    70. RUOCCO NA; BERGELSON BA; YU TK; GAVRAS I; GAVRAS H
      AUGMENTATION OF CORONARY BLOOD NOW BY ACE-INHIBITION - ROLE OF ANGIOTENSIN AND BRADYKININ

      Clinical and experimental hypertension
    71. GAVRAS I; MANOLIS A; GAVRAS H
      EFFECTS OF ACE-INHIBITION ON THE HEART

      Journal of human hypertension
    72. TOBIAN L; BRUNNER HR; COHN JN; GAVRAS H; LARAGH JH; MATERSON BJ; WEBER MA
      JNC-V NEITHER LIMITED NOR GUIDED BY ECONOMICS - REPLY

      American journal of hypertension
    73. HUCH KM; RUNYAN KR; WALL BM; GAVRAS H; COOKE CR
      HEMODYNAMIC-RESPONSE TO VASOPRESSIN DURING V-1-RECEPTOR ANTAGONISM INBAROREFLEX-DEFICIENT SUBJECTS

      American journal of physiology. Regulatory, integrative and comparative physiology
    74. HANDY DE; ZANELLA MT; KANEMARU A; TAVARES A; FLORDELLIS C; GAVRAS H
      A NEGATIVE REGULATORY ELEMENT IN THE PROMOTER REGION OF THE RAT ALPHA(2)A-ADRENERGIC RECEPTOR GENE OVERLAPS AN SP1 CONSENSUS BINDING-SITE

      Biochemical journal
    75. KOHLMANN O; GINOZA M; CEZARETTI ML; ZANELLA MT; RIBEIRO AB; TAVARES A; RAMOS OL; LEEMAN SE; GAVRAS I; GAVRAS H
      CARDIOVASCULAR EFFECTS OF A SPECIFIC NONPEPTIDE ANTAGONIST OF SUBSTANCE-P (NK-1) RECEPTOR IN DOCA-SALT HYPERTENSION

      Hypertension
    76. MANOLIS AJ; OLYMPIOS C; SIFAKI M; HANDANIS S; BRESNAHAN M; GAVRAS I; GAVRAS H
      SUPPRESSING SYMPATHETIC ACTIVATION IN CONGESTIVE-HEART-FAILURE - A NEW THERAPEUTIC STRATEGY

      Hypertension
    77. HAEFLIGER JA; BERGONZELLI G; WAEBER G; AUBERT JF; NUSSBERGER J; GAVRAS H; NICOD P; WAEBER B
      RENIN AND ANGIOTENSIN-II RECEPTOR GENE-EXPRESSION IN KIDNEYS OF RENALHYPERTENSIVE RATS

      Hypertension
    78. HANDY DE; GAVRAS H
      CELL-SPECIFIC REGULATION OF ALPHA(2A)-ADRENERGIC RECEPTOR GENE-TRANSCRIPTION

      Hypertension
    79. KOHLMANN O; GINOZA M; CESARETTI ML; ZANELLA MT; RIBEIRO AB; LEEMAN SE; GAVRAS I; GAVRAS H; DEMEDICINA EP
      CARDIOVASCULAR EFFECTS OF A SPECIFIC NONPEPTIDE ANTAGONIST OF SUBSTANCE-P RECEPTOR IN EXPERIMENTAL-HYPERTENSION

      Hypertension
    80. MANOLIS AJ; OLYMPIOS C; SIFAKI M; HANDANIS S; BRESNAHAN M; GAVRAS I; GAVRAS H
      REDUCTION OF SYMPATHETIC ACTIVITY IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE

      Hypertension
    81. KOHLMANN O; GINOZA M; CESARETI ML; ZANELLA MT; RIBEIRO AB; GAVRAS I; GAVRAS H
      ROLE FOR SUBSTANCE-P IN EXPERIMENTAL-HYPERTENSION

      Hypertension
    82. KOHLMAN O; DEASSIS F; NEVES R; GINOZA M; TAVARES A; CEZARETTI ML; ZANELLA MT; RIBEIRO AB; GAVRAS I; GAVRAS H
      ROLE OF BRADYKININ IN INSULIN SENSITIVITY AND FLOOD PRESSURE REGULATION DURING HYPERINSULINEMIA

      Hypertension
    83. MANOLIS AJ; GAVRAS I; PIEPRZAK M; GAVRAS H
      ISRADIPINE VERSUS CAPTOPRIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION

      Clinical therapeutics
    84. FLORDELLIS CS; BERGUERAND M; GOUACHE P; BARBU V; GAVRAS H; HANDY DE; BEREZIAT G; MASLIAH J
      ALPHA(2) ADRENERGIC-RECEPTOR SUBTYPES EXPRESSED IN CHINESE-HAMSTER OVARY CELLS ACTIVATE DIFFERENTIALLY MITOGEN-ACTIVATED PROTEIN-KINASE BY A P21(RAS) INDEPENDENT PATHWAY

      The Journal of biological chemistry
    85. GAVRAS H; GAVRAS I
      ON THE JNC-V REPORT - A DIFFERENT POINT-OF-VIEW

      American journal of hypertension
    86. TOBIAN L; BRUNNER HR; COHN JN; GAVRAS H; LARAGH JH; MATERSON BJ; WEBER MA
      MODERN STRATEGIES TO PREVENT CORONARY SEQUELAE AND STROKE IN HYPERTENSIVE PATIENTS DIFFER FROM THE JNC-V CONSENSUS GUIDELINES

      American journal of hypertension
    87. TAVARES A; HANDY DE; BOGDANOVA N; ROSENE D; GAVRAS H
      DETECTION OF RAT ALPHA2 ADRENERGIC-RECEPTOR (ALPHA(2)-AR) TRANSCRIPTSIN-SITU HYBRIDIZATION

      Hypertension
    88. GAVRAS H
      ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND THE HEART

      Hypertension
    89. FRANCO R; GUT A; FERRARISPADOTTO A; GEORGETTE J; GAVRAS I; GAVRAS H
      PRESSER MECHANISMS IN ADRIAMYCIN-INDUCED NEPHROPATHY WITH HYPERTENSION IN RATS

      Hypertension
    90. BURSZTYN M; GAVRAS I; GOURLEY L; DESILVA J; WHALEN J; GAVRAS H
      EFFECT OF COMBINATION THERAPY WITH ATENOLOL AND THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR BENAZEPRIL

      Clinical therapeutics
    91. KOHLMANN O; NEVES FAR; GINOZA M; CEZARETTI ML; TAVARES A; RIBEIRO AB; GAVRAS I; GAVRAS H
      BRADYKININ INHIBITION INDUCES INSULIN-RESISTANCE AND INCREASES BLOOD-PRESSURE DURING HYPERINSULINEMIA

      Kidney international
    92. GAVRAS I; GAVRAS H
      ACE-INHIBITORS - A DECADE OF CLINICAL-EXPERIENCE

      Hospital practice
    93. DEPAULA RB; PLAVNIK FL; RODRIGUES CIS; NEVES FDR; KOHLMANN O; RIBEIRO AB; GAVRAS I; GAVRAS H
      CONTRIBUTION OF VASOPRESSIN TO ORTHOSTATIC BLOOD-PRESSURE MAINTENANCEIN ESSENTIAL-HYPERTENSION

      American journal of hypertension
    94. HANDY DE; FLORDELLIS CS; BOGDANOVA NN; BRESNAHAN MR; GAVRAS H
      DIVERSE TISSUE EXPRESSION OF RAT ALPHA(2)-ADRENERGIC RECEPTOR GENES

      Hypertension
    95. LAMMEK B; KAZMIERKIEWICZ R; ITO Y; GAVRAS H
      NEW POTENT B(2)-BRADYKININ ANTAGONISTS ACYLATED WITH BULKY SUBSTITUENTS ON THEIR N-TERMINALS

      Polish Journal of Chemistry
    96. HUCH KM; WALL BM; MANGOLD T; BOBAL MA; GAVRAS H; COOKE CR
      THE ROLE OF AVP IN BLOOD-PRESSURE CONTROL DURING POSTURAL STRESS IN QUADRIPLEGIC SUBJECTS

      Clinical research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 17:38:34